Home » MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES

MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES

May 17, 2006

Medtronic Inc. announced that it received FDA approval of its Concerto/Virtuoso line of implantable cardiac devices, its next generation of cardiac rhythm disease management products.
Trading Markets Live

KEYWORDS FDAnews Device Daily Bulletin

08Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers
11Oct
1st Annual Quality Management vSummit

MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

1st Annual Quality Management vSummit

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

AngioDynamics Gets Expanded Clearance for Auryon Atherectomy System

Aura Biosciences Receives Fast Track Designation for Bladder Cancer Candidate

FDA Issues Update on Becton Dickinson’s Recall

FDA Grants Accelerated Approval to Enhertu for HER2-Mutant NSCLC

The Revised ICH E8: A Guide to New Clinical Trial Requirements